In vivo inducible reverse genetics in patients’ tumors to identify individual therapeutic targets

High-throughput sequencing describes multiple alterations in individual tumors, but their functional relevance is often unclear. Clinic-close, individualized molecular model systems are required for functional validation and to identify therapeutic targets of high significance for each patient. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlet, Michela, Völse, Kerstin, Vergalli, Jenny, Becker, Martin, Herold, Tobias, Arner, Anja, Senft, Daniela, Jurinovic, Vindi, Liu, Wen-Hsin, Gao, Yuqiao, Dill, Veronika, Fehse, Boris, Baldus, Claudia D., Bastian, Lorenz, Lenk, Lennart, Schewe, Denis M., Bagnoli, Johannes W., Vick, Binje, Schmid, Jan Philipp, Wilhelm, Alexander, Marschalek, Rolf, Jost, Philipp J., Miething, Cornelius, Riecken, Kristoffer, Schmidt-Supprian, Marc, Binder, Vera, Jeremias, Irmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476619/
https://www.ncbi.nlm.nih.gov/pubmed/34580292
http://dx.doi.org/10.1038/s41467-021-25963-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476619/
https://www.ncbi.nlm.nih.gov/pubmed/34580292
http://dx.doi.org/10.1038/s41467-021-25963-z

Ejemplares similares